DarioHealth
DRIO
63 hedge funds and large institutions have $63.7M invested in DarioHealth in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 7 closing their positions.
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
11% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 19
5% more funds holding
Funds holding: 60 → 63 (+3)
0.18% more ownership
Funds ownership: 2.34% → 2.52% (+0.18%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
37% less capital invested
Capital invested by funds: $101M → $63.7M (-$36.8M)
65% less call options, than puts
Call options by funds: $246K | Put options by funds: $696K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$13.3M |
| 2 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$8.83M |
| 3 |
AWAM
Appian Way Asset Management
New York
|
+$3.61M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.52M |
| 5 |
LC
L1 Capital
Melbourne VIC 3000,
Australia
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$3.37M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$494K |
| 3 |
Morgan Stanley
New York
|
-$340K |
| 4 |
Citigroup
New York
|
-$230K |
| 5 |
BlackRock
New York
|
-$187K |
DRIO Hedge Fund Activity: Q1 2022 in Review
63 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q1 2022, worth a combined $63.7M — down 37% from $101M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new DRIO positions and 7 closed out — a net gain of 4 holders — while 21 added to existing stakes and 19 trimmed.
The largest buyer was Clal Insurance, opening a new position worth an estimated $13.3M. The largest seller was Farallon Capital Management, cutting an estimated $3.37M.
- 63 institutional investors held DarioHealth (DRIO) as of Q1 2022, up from 60 in Q4 2021.
- Funds reported $63.7M of DarioHealth stock for Q1 2022, down 37% quarter-over-quarter.
- 11 funds opened new DarioHealth positions in Q1 2022 and 7 closed out, a net change of +4 holders.
- The largest DarioHealth buyer in Q1 2022 was Clal Insurance, an estimated $13.3M added.
- The largest DarioHealth seller in Q1 2022 was Farallon Capital Management, an estimated $3.37M sold.
Based on aggregated 13F filings for Q1 2022.